Health

Mindray Revolutionizes the Way of Using Ultrasound with TE Air, Its First Wireless Handheld Ultrasound System

SHENZHEN, China, Feb. 15, 2023 /PRNewswire/ -- Mindray (SZSE: 300760), one of the world's leading developers and providers of advanced medical devices and solutions, recently launched its first wireless handheld ultrasound system, the TE Air.

2023-02-15 14:40 3109

Towards Inexpensive and Highly Conductive Anion-Exchange Membranes: WPI-MANA

TSUKUBA, Japan, Feb. 15, 2023 /PRNewswire/ -- An international research team at the International Center for Materials Nanoarchitectonics (WPI-MANA) has worked to improve the ionic conductivity of anion-exchange membranes (AEMs) made from layered double hydroxides (LDHs), laying the foundation fo...

2023-02-15 14:00 1551

GILEAD TO PRESENT DATA AT APASL 2023 ON EFFECTIVE MODELS FOR MONITORING AND TREATING HEPATITIS C AND EFFICACY OF ANTIVIRAL TREATMENTS FOR HIV-1 AND HBV-COINFECTED ADULTS

- Study recommends a simplified strategy for baseline testing and minimal monitoring for treatment of hepatitis C virus (HCV) infection with DAA Therapies - Review of implementation science projects toward HCV Elimination by 2030 in Asia proved effective in improving patient outcomes - Efficacy ...

2023-02-15 10:00 2414

Innovent Announces First Participant Dosed in Phase 2 Study of IBI311 (Anti-IGF-1R Monoclonal Antibody) in Patients with Thyroid Associated Ophthalmopathy

ROCKVILLE, Md. and SUZHOU, China, Feb. 15, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology an...

2023-02-15 08:00 3571

Groundbreaking clinical trial underway to improve vision in individuals with advanced Retinitis Pigmentosa (RP)

Putting Australian clinical research on the map globally, comes the ground-breaking first-in-human clinical trial for KIO-301. MELBOURNE, Australia, Feb. 15, 2023 /PRNewswire/ -- In collaboration with US-based Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) and The Royal Adelaide Hospital, leading Au...

2023-02-15 05:10 1936

Telix Collaboration on Next Generation Urologic-Oncology Theranostic Published in Journal of Nuclear Medicine

MELBOURNE, Australia, Feb. 15, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the successful completion of its joint research project conducted with Heidelberg University Hospital (UKHD) under the Research Cooperation Agreement announced inFebrua...

2023-02-15 04:51 1853

Eluminex Biosciences Announces Completion of Initial Enrollment in Part A of the CLARITY Study Evaluating a Human Recombinant Collagen-derived (rhCIII) Biosynthetic Cornea (EB-301)

Initial Part A results to be presented at the upcoming American Society of Cataract and Refractive Surgery Annual Meeting EB-301 has the potential to be the world's first approved rhCIII biosynthetic corneal implant for the treatment of corneal blindness SUZHOU, China and SAN FRANCISCO, Feb. 14,...

2023-02-15 01:00 1752

Eurofins Discovery Collaborating with Invasight on Cancer Therapies

SAN DIEGO, Feb. 14, 2023 /PRNewswire/ -- Eurofins Discovery, the leading provider of products and services to the drug discovery industry, today announced its collaboration withInvasight, a Switzerland-based biotech developing cancer therapies. The collaboration focuses on advancing first-in-cla...

2023-02-15 00:10 2035

CJ Biomaterials Teams with Banila Co. to Develop New 100% Biobased Cosmetic Jar using Amorphous PHA

WOBURN, Mass., Feb. 14, 2023 /PRNewswire/ -- CJ Biomaterials, Inc., a division ofSouth Korea-based CJ CheilJedang and a primary producer of polyhydroxyalkanoates (PHAs), has produced the first cosmetic jar based on their amorphous PHA technology, under the tradename, PHACT™. The cosmetic jar was...

2023-02-14 22:00 2183

Waterdrop CEO Peng Shen Elected as a Member of the School Affairs Council of HKU Business School

BEIJING, Feb. 14, 2023 /PRNewswire/ -- On February 9, HKU Business School announced the new membership list for the School Affairs Council. After nomination and voting by HKU Business School's alumni and publicity by the school,Peng Shen, Founder and CEO of Waterdrop, was elected as a member of t...

2023-02-14 21:32 3515

Metabolon to Offer Targeted Panels and Assays to Aid in Dysregulated Glucose Status and Related Research

Targeted metabolomics panels and assays provide absolute quantitation for advanced research into the relationship of metabolites to glucose metabolism MORRISVILLE, N.C., Feb. 14, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variet...

2023-02-14 21:04 1857

CJ FNT was Globally Launched to Become a 'Total Solutions Provider' in the Food & Nutrition Market

- Synergizing the bio and food business competencies to target the global market for food & nutritional ingredient solutions SEOUL, South Korea, Feb. 14, 2023 /PRNewswire/ -- CJ Food&Nutrition Tech (CJ FNT), a newly established business unit withinSouth Korea-based food & bio company CJ CheilJed...

2023-02-14 21:00 2042

Athachi Group showcases 'Trust Nature™' initiative to Union Ministers; The 'Trust Nature™' philosophy is akin to Yoga to the world

NEW DELHI, Feb. 14, 2023 /PRNewswire/ -- The senior management team of Athachi Group, a diversified business group headquartered in Palakkad, Kerala, with nature close to its heart across its operations inIndia and the UAE, met the Union Ministers recently in the capital and presented its 'Trust ...

2023-02-14 11:30 2240

Havas Health & You Appoints Internationally Recognized Creative Alex Okada as Chief Creative Officer of Havas Lynx Group

NEW YORK, Feb. 13, 2023 /PRNewswire/ -- As the world's largest health and wellness network, Havas Health & You (HH&Y) is building on its creative momentum by appointingAlex Okada as CCO of Havas Lynx Group, one of its leading health communications agencies. Alex joined Havas Lynx Group onFebruary...

2023-02-13 22:15 2034

HistoSonics Announces FDA Approval of its Pivotal IDE #HOPE4KIDNEY Trial

Company to Utilize its New Edison™ System with Advanced Imaging Features for Use in Kidney Tumors MINNEAPOLIS, Feb. 13, 2023 /PRNewswire/ -- HistoSonics, (www.histosonics.com ), the developer of a non-invasive platform and novel sonic beam therapy called histotripsy, announced today the US Food a...

2023-02-13 22:00 1865

Point-of-Care Ultrasound Training in Under-Resourced Region Improves Physician Knowledge

Study of 100+ Patients Published in Journal of Radiology Nursing ROCKVILLE, Md., Feb. 13, 2023 /PRNewswire/ -- A study published for the March 2023 issue of Journal of Radiology Nursing demonstrates that a short training course in Point-of-Care Ultrasound (POCUS) can measurably improve physician...

2023-02-13 22:00 1746

AnPac Bio-Medical Science Enters into Definitive Agreement to Make Another Acquisition to Significantly Expand Scope of Business in the U.S.

NEW YORK, Feb. 13, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operations inthe United States andChina announced that on February 12, 2023, the Company, through its subsidiary Foodbase Group Inc., entered into a definitive equity purchas...

2023-02-13 21:00 3429

Randomized Controlled Trial Backs Clinical Efficacy of Lunit AI for Chest X-Ray

* First-ever randomized controlled trial regarding deep learning-based AI in radiology provides strong evidence for the clinical value of AI * Large-scale study with 10,476 patients published in Radiology, the top journal in radiology SEOUL, South Korea, Feb. 13, 2023 /PRNewswire/ -- Findings ...

2023-02-13 21:00 1718

Ansell Applauded by Frost & Sullivan for Protecting Clinicians and Patients Using Latex-free Gloves, and Its Market-leading Position

Ansell's solutions combine an ergonomic design and skin-friendly technology to shield surgeons' and clinicians' hands, their most valuable asset in delivering care, and supporting their overall quality of life. SAN ANTONIO, Feb. 13, 2023 /PRNewswire/ -- Recently, Frost & Sullivan analyzed the me...

2023-02-13 21:00 1786

U.S. Government and Novavax Extend Partnership, Securing Up to 1.5 Million Additional Doses of Novavax' COVID-19 Vaccine

* Modified agreement also includes the development of an updated vaccine in fall 2023 GAITHERSBURG, Md., Feb. 13, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, toda...

2023-02-13 21:00 2844
1 ... 226227228229230231232 ... 830